Loss-of-function variants in myocardin cause congenital megabladder in humans and mice

Arjan C. Houweling, Glenda M. Beaman, Alex V. Postma, T. Blair Gainous, Klaske D. Lichtenbelt, Francesco Brancati, Filipa M. Lopes, Ingeborg Van Der Made, Abeltje M. Polstra, Michael L. Robinson, Kevin D. Wright, Jamie M. Ellingford, Ashley R. Jackson, Eline Overwater, Rita Genesio, Silvio Romano, Letizia Camerota, Emanuela D'Angelo, Elizabeth J. Meijers-Heijboer, Vincent M. ChristoffelsKirk M. McHugh, Brian L. Black, William G. Newman, Adrian S. Woolf, Esther E. Creemers

Research output: Contribution to journalArticle

Abstract

Myocardin (MYOCD) is the founding member of a class of transcriptional coactivators that bind the serum-response factor to activate gene expression programs critical in smooth muscle (SM) and cardiac muscle development. Insights into the molecular functions of MYOCD have been obtained from cell culture studies, and to date, knowledge about in vivo roles of MYOCD comes exclusively from experimental animals. Here, we defined an often lethal congenital human disease associated with inheritance of pathogenic MYOCD variants. This disease manifested as a massively dilated urinary bladder, or megabladder, with disrupted SM in its wall. We provided evidence that monoallelic loss-of-function variants in MYOCD caused congenital megabladder in males only, whereas biallelic variants were associated with disease in both sexes, with a phenotype additionally involving the cardiovascular system. These results were supported by cosegregation of MYOCD variants with the phenotype in 4 unrelated families by in vitro transactivation studies in which pathogenic variants resulted in abrogated SM gene expression and by the finding of megabladder in 2 distinct mouse models with reduced Myocd activity. In conclusion, we have demonstrated that variants in MYOCD result in human disease, and the collective findings highlight a vital role for MYOCD in mammalian organogenesis.

Original languageEnglish
Pages (from-to)5374-5380
Number of pages7
JournalJournal of Clinical Investigation
Volume129
Issue number12
DOIs
Publication statusPublished - Dec 2 2019

    Fingerprint

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Houweling, A. C., Beaman, G. M., Postma, A. V., Blair Gainous, T., Lichtenbelt, K. D., Brancati, F., Lopes, F. M., Van Der Made, I., Polstra, A. M., Robinson, M. L., Wright, K. D., Ellingford, J. M., Jackson, A. R., Overwater, E., Genesio, R., Romano, S., Camerota, L., D'Angelo, E., Meijers-Heijboer, E. J., ... Creemers, E. E. (2019). Loss-of-function variants in myocardin cause congenital megabladder in humans and mice. Journal of Clinical Investigation, 129(12), 5374-5380. https://doi.org/10.1172/JCI128545